Mobile Menu

Liquid biopsy: From discovery to clinical implementation

Liquid biopsy: From discovery to clinical implementation
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf

You may also like

The Forefront of Genomics: Opportunities, Challenges, and Imperatives
Eric Green, Director, National Human Genome Research Institute (NHGRI)
All of Us Research Program: Advancing Precision Health for All Populations
Stephanie Devaney, Chief Operating Officer, All of Us Research Programme,National Institutes of Health (NIH)
Rare Disease as an Emerging Field of Medicine
Marshall Summar, Director, Rare Disease Institute, Children’s National Health System
UK Biobank: Going Beyond Genomics in 2022
Mark Effingham, Deputy Chief Executive Officer, UK Biobank
The Future of Genomics: Health and Beyond
Sir Patrick Vallance, Government Chief Scientific Adviser, UK Government
How Genomics is Changing the Shape of Healthcare: England’s NHS Continues its Momentum
Dame Sue Hill, Chief Scientific Officer, NHS England and NHS Improvement

Page 2 of 2

Share this article